Veterinary Medicine Information website

Drontal Dog Tasty Bone XL 525/504/175 mg tablets

Authorised
  • Febantel
  • Praziquantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
Drontal Dog Tasty Bone XL 525/504/175 mg tablets
Active substance:
  • Febantel
  • Praziquantel
  • Pyrantel embonate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Febantel
    525.00
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    175.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    504.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:
  • Container material: Blisters formed from PA/Alu/PE foil and sealed with Alu/PE foil. Container size: Cartons containing 48 tablets.
  • Container material: Blisters formed from PA/Alu/PE foil and sealed with Alu/PE foil. Container size: Cartons containing 24 tablets.
  • Container material: Blisters formed from PA/Alu/PE foil and sealed with Alu/PE foil. Container size: Cartons containing 8 tablets.
  • Container material: Blisters formed from PA/Alu/PE foil and sealed with Alu/PE foil. Container size: Cartons containing 4 tablets.
  • Container material: Blisters formed from PA/Alu/PE foil and sealed with Alu/PE foil. Container size: Cartons containing 2 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Europeenne De Pharmacotechnie Europhartech
  • KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 119735
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0335/002
Concerned member states:
  • Austria
  • Denmark
  • Finland
  • France
  • Germany
  • Iceland
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 26/01/2022
Download

Summary of Product Characteristics

English (PDF)
Published on: 26/08/2024
Download